Aptorum Group Ltd Class A (NASDAQ:APM)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - APM

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - APM

  • Market Cap$122.440m
  • SymbolNASDAQ:APM
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINKYG6096M1069

Company Profile

Aptorum Group Ltd is a pharmaceutical company. It is engaged in the discovery, development, and commercializing of therapeutic assets to treat diseases with unmet medical needs, particularly infectious diseases and cancers. The pipeline of Aptorum is also enriched through the establishment of drug discovery platforms that enable the discovery of new therapeutics assets through, e.g. systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases. The firm is also seeking therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, and other disease areas. It also has projects focused on surgical robotics and natural supplement for women undergoing menopause and experiencing related symptoms.

Latest APM news

Currently there for this company. Visit our news hub for other news .